ArticleNature communications2026
A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Article
- The Invasive Margin of Glioblastoma as a Molecular Ecosystem: Spatial Heterogeneity, Tumor-Host Interactions, and Therapeutic Opportunities.International journal of molecular sciences · 2026Review
- The Origin of Cancer-Associated Fibroblasts (CAFs) in Brain Metastases: Seven Hypotheses and Current Evidence.Cancers · 2026Review
- T2Pdecoder enables protein-centric analyses from transcriptomic data.Nature communications · 2026Article
- Integrative Multi-Omics Analysis Identifies anGenes · 2026Article
- A Synaptogenesis-Associated Histomorphologic Signature from H&E Whole-Slide Images Predicts Glioma Prognosis and IdentifiesInternational journal of molecular sciences · 2026Article
- Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.Molecular biomedicine · 2026Review
- Tumor-neuronal hybrid programs reveal a spatially adaptive malignant state in glioblastoma.Frontiers in oncology · 2026Article
- BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFCell reports. Medicine · 2025Article
- Robust Cluster Prediction Across Data Types Validates Association of Sex and Therapy Response in GBM.Cancers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Glioblastoma is an aggressive brain cancer with limited treatment options and poor patient survival, driven in part by cellular diversity within tumors. While individual cell types have been catalogued, how malignant, vascular, and immune cells are spatially organized inside human tumors remains incompletely understood. Here we show a spatially resolved, multi-modal atlas of human glioblastoma that integrates gene expression profiling across tissue sections with matched single-cell and protein measurements at subcellular resolution. Using a targeted 348 gene panel enriched for vascular and stromal markers, we identify less well-characterized endothelial, perivascular, and fibroblast-like cell states and define their spatial associations with malignant and immune compartments. We further identify a distinct oligodendrocyte population restricted to tumor core and perivascular regions that exhibits gene expression patterns associated with tumor recurrence and poor clinical outcome. This publicly accessible atlas provides a high-resolution framework for studying the spatial organization of glioblastoma and highlights region-specific cellular interactions that may represent therapeutically actionable vulnerabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.